Definitive Contract 75N93024C00049
Award Date
8/15/24
Potential Completion Date
8/14/25
Potential Value
$300K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Lynntech Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Charlottesville, VA, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
7
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Lynntech Inc., a small business based in College Station, Texas. The $599,989 firm-fixed-price contract is for the development of "B-SMART - Broadly Neutralizing Antibodies for SARNA Mediated Antiviral Response Therapy", which aligns with NIAID's mission to conduct and support...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, has awarded a Small Business Innovation Research (SBIR) Phase I Definitive Contract with a ceiling value of $299,326.00 to Lynntech Inc., a small business technology development company based in College Station, Texas. The contract requires Lynntech to design and develop a novel "3IN1" approach to efficiently collect samples (blood, sputum, urine) in field locations to support surveillance...
The U.S. Department of Health and Human Services, National Institute of Allergy and Infectious Diseases (NIAID) awarded a Small Business Innovation Research (SBIR) Phase I contract to Lynntech Inc., a small business technology development company based in College Station, Texas. The contract, valued at $223,568.00, is for the development of a "Simple, Inexpensive Unit for Removing Cells from Small Amounts of Blood in Resource-Limited Settings." This contract is a Firm Fixed Price...
This is a federal contract award to Lynntech Inc., a small business technology development company based in College Station, Texas. The contract, valued at $299,997.00, was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), under the Small Business Innovation Research (SBIR) program. The contract is for the development of a Rapid Point-of-Care HIV Viral Load Test, which aligns with NIAID's mission to conduct and...
This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Lynntech Inc., a small business technology development company based in College Station, Texas. The contract, valued at $149,793.87, is for research and development related to the causative agents of schistosomiasis and onchocerciasis. The contract is not designated as a set-aside. Lynntech Inc. has extensive experience conducting contracted...
This is a $999,999.00 SBIR Phase II contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Lynntech Inc., a small business that provides research, development, testing, and evaluation services to U.S. federal agencies. The contract is a cost-plus-fixed-fee definitive contract with an April 3, 2020 completion date. Lynntech has received various federal research and development contracts and grants, including from the Department of Defense,...
This is a $2,088,942.54 Cost Plus Fixed Fee contract awarded by the Department of the Army Medical Command to Lynntech Inc., a small business technology development company in College Station, Texas. The contract is for a Phase II Small Business Innovation Research (SBIR) effort to develop a point-of-care test for disease severity and risk stratification. The research is being conducted under SBIR Proposal #H2-0383, with a completion date of January 11, 2025. Lynntech has previously received...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, awarded a $10,650.00 firm fixed-price purchase order contract to Scale Biosciences, Inc. for the procurement of RNA kits. This contract has a total small business set-aside designation and a period of performance through December 31, 2024. As NIAID is responsible for conducting and supporting research to understand, treat, and prevent infectious diseases, this contract award is likely related to their...
This is a $299,999.00 Firm Fixed Price Definitive Contract awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Luna Innovations Incorporated, a small business manufacturer, for the CNT-VECTORED DELIVERY OF MRNA FOR HIV-VACCINES research project under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for the development and delivery of products and services related to this...
This is a $599,998.00 firm fixed price contract awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Melax Technologies Inc., a for-profit small business. The contract was awarded under the Small Business Innovation Research (SBIR) program, which does not have a set-aside designation, to conduct research and development of advanced data analytics technologies focused on healthcare applications. The work is being performed in Houston,...